REGN logo

REGN Free cash flow

annual FCF:

$3.54B-$128.70M(-3.51%)
December 31, 2024

Summary

  • As of today (June 2, 2025), REGN annual free cash flow is $3.54 billion, with the most recent change of -$128.70 million (-3.51%) on December 31, 2024.
  • During the last 3 years, REGN annual FCF has fallen by -$2.99 billion (-45.80%).
  • REGN annual FCF is now -45.80% below its all-time high of $6.53 billion, reached on December 31, 2021.

Performance

REGN Free cash flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

quarterly FCF:

$773.60M-$222.20M(-22.31%)
March 31, 2025

Summary

  • As of today (June 2, 2025), REGN quarterly free cash flow is $773.60 million, with the most recent change of -$222.20 million (-22.31%) on March 31, 2025.
  • Over the past year, REGN quarterly FCF has dropped by -$577.10 million (-42.73%).
  • REGN quarterly FCF is now -76.42% below its all-time high of $3.28 billion, reached on September 30, 2021.

Performance

REGN quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

TTM FCF:

$2.96B-$577.10M(-16.31%)
March 31, 2025

Summary

  • As of today (June 2, 2025), REGN TTM free cash flow is $2.96 billion, with the most recent change of -$577.10 million (-16.31%) on March 31, 2025.
  • Over the past year, REGN TTM FCF has dropped by -$968.00 million (-24.63%).
  • REGN TTM FCF is now -62.68% below its all-time high of $7.94 billion, reached on March 31, 2022.

Performance

REGN TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherREGNcash flow metrics

Free cash flow Formula

FCF = Cash From Operations − CAPEX

REGN Free cash flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.5%-42.7%-24.6%
3 y3 years-45.8%-60.5%-62.7%
5 y5 years+76.9%+46.5%+73.7%

REGN Free cash flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-45.8%+4.2%-60.5%+275.7%-62.7%+17.2%
5 y5-year-45.8%+76.9%-76.4%+275.7%-62.7%+87.2%
alltimeall time-45.8%+1879.2%-76.4%+275.7%-62.7%+1066.1%

REGN Free cash flow History

DateAnnualQuarterlyTTM
Mar 2025
-
$773.60M(-22.3%)
$2.96B(-16.3%)
Dec 2024
$3.54B(-3.5%)
$995.80M(-5.1%)
$3.54B(+6.6%)
Sep 2024
-
$1.05B(+633.3%)
$3.32B(+4.2%)
Jun 2024
-
$143.10M(-89.4%)
$3.18B(-19.0%)
Mar 2024
-
$1.35B(+74.0%)
$3.93B(+7.1%)
Dec 2023
$3.67B(+7.9%)
$776.20M(-15.1%)
$3.67B(-15.9%)
Sep 2023
-
$914.40M(+2.9%)
$4.36B(+45.1%)
Jun 2023
-
$888.50M(-18.4%)
$3.00B(+18.9%)
Mar 2023
-
$1.09B(-25.8%)
$2.53B(-25.6%)
Dec 2022
$3.40B(-48.0%)
$1.47B(-433.3%)
$3.40B(-18.1%)
Sep 2022
-
-$440.40M(-207.2%)
$4.15B(-47.3%)
Jun 2022
-
$410.80M(-79.0%)
$7.87B(-0.8%)
Mar 2022
-
$1.96B(-11.6%)
$7.94B(+21.5%)
Dec 2021
$6.53B(+225.9%)
$2.22B(-32.4%)
$6.53B(+21.3%)
Sep 2021
-
$3.28B(+586.0%)
$5.38B(+217.8%)
Jun 2021
-
$478.20M(-13.6%)
$1.69B(-16.5%)
Mar 2021
-
$553.20M(-48.3%)
$2.03B(+1.3%)
Dec 2020
$2.00B(+0.2%)
$1.07B(-362.5%)
$2.00B(+26.6%)
Sep 2020
-
-$407.50M(-150.1%)
$1.58B(-34.8%)
Jun 2020
-
$813.50M(+54.1%)
$2.43B(+42.2%)
Mar 2020
-
$527.90M(-18.6%)
$1.71B(-14.7%)
Dec 2019
$2.00B(+10.4%)
$648.40M(+48.9%)
$2.00B(+0.3%)
Sep 2019
-
$435.60M(+364.9%)
$2.00B(+4.7%)
Jun 2019
-
$93.70M(-88.6%)
$1.91B(-9.0%)
Mar 2019
-
$822.70M(+27.9%)
$2.10B(+15.6%)
Dec 2018
$1.81B(+75.2%)
$643.30M(+85.5%)
$1.81B(+11.3%)
Sep 2018
-
$346.70M(+22.7%)
$1.63B(-0.5%)
Jun 2018
-
$282.60M(-47.6%)
$1.64B(+29.0%)
Mar 2018
-
$539.40M(+17.4%)
$1.27B(+22.6%)
Dec 2017
$1.03B(+6.2%)
$459.30M(+29.3%)
$1.03B(+26.9%)
Sep 2017
-
$355.18M(-515.8%)
$815.17M(-17.9%)
Jun 2017
-
-$85.42M(-128.0%)
$992.46M(-25.9%)
Mar 2017
-
$305.44M(+27.3%)
$1.34B(+37.4%)
Dec 2016
$974.00M(+49.2%)
$239.97M(-54.9%)
$974.00M(+16.2%)
Sep 2016
-
$532.47M(+104.3%)
$838.08M(-20.4%)
Jun 2016
-
$260.66M(-541.0%)
$1.05B(+30.0%)
Mar 2016
-
-$59.10M(-156.8%)
$809.63M(+24.0%)
Dec 2015
$652.85M(+55.7%)
$104.04M(-86.1%)
$652.85M(+3.7%)
Sep 2015
-
$746.75M(+4063.0%)
$629.44M(-2021.0%)
Jun 2015
-
$17.94M(-108.3%)
-$32.77M(-115.3%)
Mar 2015
-
-$215.89M(-367.7%)
$214.84M(-48.8%)
Dec 2014
$419.43M(-3.0%)
$80.63M(-4.6%)
$419.43M(-24.0%)
Sep 2014
-
$84.55M(-68.2%)
$551.55M(+4.5%)
Jun 2014
-
$265.54M(-2450.9%)
$527.76M(+48.3%)
Mar 2014
-
-$11.29M(-105.3%)
$355.93M(-17.7%)
Dec 2013
$432.27M(-448.7%)
$212.75M(+250.1%)
$432.27M(+45.3%)
Sep 2013
-
$60.76M(-35.2%)
$297.54M(+32.7%)
Jun 2013
-
$93.71M(+44.1%)
$224.15M(+472.0%)
Mar 2013
-
$65.05M(-16.6%)
$39.19M(-131.6%)
Dec 2012
-$123.95M(-37.7%)
$78.02M(-717.8%)
-$123.95M(-53.0%)
Sep 2012
-
-$12.63M(-86.2%)
-$263.58M(-14.0%)
Jun 2012
-
-$91.25M(-7.0%)
-$306.58M(+16.0%)
Mar 2012
-
-$98.10M(+59.2%)
-$264.25M(+32.9%)
Dec 2011
-$198.90M(>+9900.0%)
-$61.61M(+10.7%)
-$198.90M(-5.5%)
Sep 2011
-
-$55.63M(+13.7%)
-$210.41M(+1268.5%)
Jun 2011
-
-$48.91M(+49.4%)
-$15.38M(+1623.7%)
Mar 2011
-
-$32.75M(-55.2%)
-$892.00K(+91.0%)
Dec 2010
-$467.00K(-99.7%)
-$73.11M(-152.4%)
-$467.00K(-111.9%)
Sep 2010
-
$139.40M(-504.9%)
$3.93M(-102.3%)
Jun 2010
-
-$34.43M(+6.5%)
-$167.63M(+1.9%)
Mar 2010
-
-$32.32M(-53.0%)
-$164.57M(-2.9%)
Dec 2009
-$169.55M(+36.8%)
-$68.72M(+113.7%)
-$169.55M(+11.2%)
Sep 2009
-
-$32.15M(+2.5%)
-$152.41M(-10.9%)
Jun 2009
-
-$31.38M(-15.9%)
-$171.13M(+22.0%)
Mar 2009
-
-$37.30M(-27.7%)
-$140.30M(+13.2%)
Dec 2008
-$123.94M
-$51.58M(+1.4%)
-$123.94M(+284.0%)
Sep 2008
-
-$50.87M(+9234.7%)
-$32.28M(-1106.7%)
DateAnnualQuarterlyTTM
Jun 2008
-
-$545.00K(-97.4%)
$3.21M(-302.5%)
Mar 2008
-
-$20.94M(-152.2%)
-$1.58M(-117.7%)
Dec 2007
$8.93M(-56.0%)
$40.09M(-360.4%)
$8.93M(-57.4%)
Sep 2007
-
-$15.39M(+188.6%)
$20.93M(+0.3%)
Jun 2007
-
-$5.33M(-48.9%)
$20.88M(+301.7%)
Mar 2007
-
-$10.44M(-120.0%)
$5.20M(-74.4%)
Dec 2006
$20.26M(-157.5%)
$52.09M(-437.2%)
$20.26M(-138.9%)
Sep 2006
-
-$15.45M(-26.5%)
-$52.03M(-2.4%)
Jun 2006
-
-$21.02M(-553.7%)
-$53.30M(-14.6%)
Mar 2006
-
$4.63M(-122.9%)
-$62.40M(+77.0%)
Dec 2005
-$35.26M(+52.8%)
-$20.20M(+20.8%)
-$35.26M(+23.3%)
Sep 2005
-
-$16.71M(-44.5%)
-$28.59M(+60.8%)
Jun 2005
-
-$30.12M(-194.8%)
-$17.77M(-162.9%)
Mar 2005
-
$31.77M(-334.9%)
$28.26M(-222.4%)
Dec 2004
-$23.08M(-35.5%)
-$13.53M(+129.3%)
-$23.08M(-41.2%)
Sep 2004
-
-$5.90M(-137.1%)
-$39.27M(-256.8%)
Jun 2004
-
$15.91M(-181.3%)
$25.05M(-168.6%)
Mar 2004
-
-$19.57M(-34.1%)
-$36.55M(+2.1%)
Dec 2003
-$35.79M(-75.3%)
-$29.71M(-150.9%)
-$35.79M(-31.5%)
Sep 2003
-
$58.42M(-227.9%)
-$52.27M(-63.4%)
Jun 2003
-
-$45.69M(+142.9%)
-$142.87M(+6.9%)
Mar 2003
-
-$18.81M(-59.3%)
-$133.65M(-7.8%)
Dec 2002
-$144.89M(+121.1%)
-$46.20M(+43.6%)
-$144.89M(+21.8%)
Sep 2002
-
-$32.17M(-11.8%)
-$118.95M(+7.7%)
Jun 2002
-
-$36.47M(+21.3%)
-$110.44M(+29.1%)
Mar 2002
-
-$30.05M(+48.4%)
-$85.56M(+30.5%)
Dec 2001
-$65.54M(+90.5%)
-$20.25M(-14.4%)
-$65.54M(+30.5%)
Sep 2001
-
-$23.66M(+104.1%)
-$50.22M(+59.0%)
Jun 2001
-
-$11.59M(+15.4%)
-$31.59M(+21.1%)
Mar 2001
-
-$10.04M(+103.4%)
-$26.09M(-24.2%)
Dec 2000
-$34.41M(+79.2%)
-$4.93M(-1.8%)
-$34.41M(+49.8%)
Sep 2000
-
-$5.03M(-17.4%)
-$22.97M(-14.4%)
Jun 2000
-
-$6.08M(-66.9%)
-$26.84M(-4.7%)
Mar 2000
-
-$18.36M(-382.4%)
-$28.16M(+46.7%)
Dec 1999
-$19.20M(+45.5%)
$6.50M(-173.0%)
-$19.20M(-40.0%)
Sep 1999
-
-$8.90M(+20.3%)
-$32.00M(+58.4%)
Jun 1999
-
-$7.40M(-21.3%)
-$20.20M(+15.4%)
Mar 1999
-
-$9.40M(+49.2%)
-$17.50M(+32.6%)
Dec 1998
-$13.20M(+61.0%)
-$6.30M(-317.2%)
-$13.20M(+200.0%)
Sep 1998
-
$2.90M(-161.7%)
-$4.40M(-53.2%)
Jun 1998
-
-$4.70M(-7.8%)
-$9.40M(+8.0%)
Mar 1998
-
-$5.10M(-304.0%)
-$8.70M(+6.1%)
Dec 1997
-$8.20M(-71.6%)
$2.50M(-219.0%)
-$8.20M(-28.1%)
Sep 1997
-
-$2.10M(-47.5%)
-$11.40M(-32.1%)
Jun 1997
-
-$4.00M(-13.0%)
-$16.80M(-21.5%)
Mar 1997
-
-$4.60M(+557.1%)
-$21.40M(-26.0%)
Dec 1996
-$28.90M(+34.4%)
-$700.00K(-90.7%)
-$28.90M(+0.3%)
Sep 1996
-
-$7.50M(-12.8%)
-$28.80M(-12.7%)
Jun 1996
-
-$8.60M(-28.9%)
-$33.00M(+22.7%)
Mar 1996
-
-$12.10M(+1916.7%)
-$26.90M(+25.1%)
Dec 1995
-$21.50M(-21.5%)
-$600.00K(-94.9%)
-$21.50M(-32.4%)
Sep 1995
-
-$11.70M(+368.0%)
-$31.80M(+19.1%)
Jun 1995
-
-$2.50M(-62.7%)
-$26.70M(+36.2%)
Mar 1995
-
-$6.70M(-38.5%)
-$19.60M(-28.5%)
Dec 1994
-$27.40M(-32.0%)
-$10.90M(+65.2%)
-$27.40M(-18.5%)
Sep 1994
-
-$6.60M(-243.5%)
-$33.60M(-1.8%)
Jun 1994
-
$4.60M(-131.7%)
-$34.20M(-27.7%)
Mar 1994
-
-$14.50M(-15.2%)
-$47.30M(+17.4%)
Dec 1993
-$40.30M(+108.8%)
-$17.10M(+137.5%)
-$40.30M(-294.7%)
Sep 1993
-
-$7.20M(-15.3%)
$20.70M(-177.5%)
Jun 1993
-
-$8.50M(+13.3%)
-$26.70M(+15.6%)
Mar 1993
-
-$7.50M(-117.1%)
-$23.10M(+19.7%)
Dec 1992
-$19.30M(+147.4%)
$43.90M(-180.4%)
-$19.30M(-69.5%)
Sep 1992
-
-$54.60M(+1014.3%)
-$63.20M(+634.9%)
Jun 1992
-
-$4.90M(+32.4%)
-$8.60M(+132.4%)
Mar 1992
-
-$3.70M
-$3.70M
Dec 1991
-$7.80M
-
-

FAQ

  • What is Regeneron Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals annual FCF year-on-year change?
  • What is Regeneron Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals quarterly FCF year-on-year change?
  • What is Regeneron Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for Regeneron Pharmaceuticals?
  • What is Regeneron Pharmaceuticals TTM FCF year-on-year change?

What is Regeneron Pharmaceuticals annual free cash flow?

The current annual FCF of REGN is $3.54B

What is the all time high annual FCF for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high annual free cash flow is $6.53B

What is Regeneron Pharmaceuticals annual FCF year-on-year change?

Over the past year, REGN annual free cash flow has changed by -$128.70M (-3.51%)

What is Regeneron Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of REGN is $773.60M

What is the all time high quarterly FCF for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high quarterly free cash flow is $3.28B

What is Regeneron Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, REGN quarterly free cash flow has changed by -$577.10M (-42.73%)

What is Regeneron Pharmaceuticals TTM free cash flow?

The current TTM FCF of REGN is $2.96B

What is the all time high TTM FCF for Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals all-time high TTM free cash flow is $7.94B

What is Regeneron Pharmaceuticals TTM FCF year-on-year change?

Over the past year, REGN TTM free cash flow has changed by -$968.00M (-24.63%)
On this page